Cargando…
Formononetin ameliorates oxaliplatin-induced peripheral neuropathy via the KEAP1-NRF2-GSTP1 axis
Management of oxaliplatin-induced peripheral neuropathy (OIPN) has proven challenging owing to the concern that any OIPN-preventing agents may also decrease the efficacy of the chemotherapeutic agent and fail to reverse established neuronal damage. Nevertheless, targeting redox signaling pathways co...
Autores principales: | Fang, Yuan, Ye, Juan, Zhao, Bing, Sun, Jinbing, Gu, Na, Chen, Xi, Ren, Lingli, Chen, Jiao, Cai, Xueting, Zhang, Wenjuan, Yang, Yang, Cao, Peng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7451796/ https://www.ncbi.nlm.nih.gov/pubmed/32823168 http://dx.doi.org/10.1016/j.redox.2020.101677 |
Ejemplares similares
-
Nomilin targets the Keap1‐Nrf2 signalling and ameliorates the development of osteoarthritis
por: Xue, Xing‐He, et al.
Publicado: (2020) -
A novel Keap1 inhibitor iKeap1 activates Nrf2 signaling and ameliorates hydrogen peroxide-induced oxidative injury and apoptosis in osteoblasts
por: Zheng, Yue-huan, et al.
Publicado: (2021) -
Role of the KEAP1-NRF2 Axis in Renal Cell Carcinoma
por: Clerici, Sara, et al.
Publicado: (2020) -
Formononetin ameliorates IL-13-induced inflammation and mucus formation in human nasal epithelial cells by activating the SIRT1/Nrf2 signaling pathway
por: Huang, Juanjuan, et al.
Publicado: (2021) -
The NRF2/KEAP1 Axis in the Regulation of Tumor Metabolism: Mechanisms and Therapeutic Perspectives
por: Panieri, Emiliano, et al.
Publicado: (2020)